Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 495


Animal models for depression associated with HIV-1 infection.

Barreto IC, Viegas P, Ziff EB, Konkiewitz EC.

J Neuroimmune Pharmacol. 2014 Mar;9(2):195-208. doi: 10.1007/s11481-013-9518-9. Epub 2013 Dec 12. Review.


Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders.

Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1197-209. doi: 10.1007/s11481-013-9511-3. Epub 2013 Nov 30.


Biomarkers for NeuroAIDS: recent progress in the field.

Fox HS.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1055-8. doi: 10.1007/s11481-013-9515-z. Epub 2013 Nov 29. No abstract available.


TNF-α/NF-κB signaling in the CNS: possible connection to EPHB2.

Pozniak PD, White MK, Khalili K.

J Neuroimmune Pharmacol. 2014 Mar;9(2):133-41. doi: 10.1007/s11481-013-9517-x. Epub 2013 Nov 27. Review.


Regulation of macrophage biology by lithium: a new look at an old drug.

Raghavendra PB, Lee E, Parameswaran N.

J Neuroimmune Pharmacol. 2014 Jun;9(3):277-84. doi: 10.1007/s11481-013-9516-y. Epub 2013 Nov 27. Review.


Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.

Cassol E, Misra V, Morgello S, Gabuzda D.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1087-97. doi: 10.1007/s11481-013-9512-2. Epub 2013 Nov 21. Review.


Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin.

Chao J, Yang L, Yao H, Buch S.

J Neuroimmune Pharmacol. 2014 Mar;9(2):259-68. doi: 10.1007/s11481-013-9509-x. Epub 2013 Nov 19.


More than two HANDs to tango.

Kolson D, Buch S.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1051-4.


Epigenetics, drugs of abuse, and the retroviral promoter.

Shirazi J, Shah S, Sagar D, Nonnemacher MR, Wigdahl B, Khan ZK, Jain P.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1181-96. doi: 10.1007/s11481-013-9508-y. Epub 2013 Nov 12. Review.


A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV.

Haughey NJ, Zhu X, Bandaru VV.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1136-46. doi: 10.1007/s11481-013-9506-0. Epub 2013 Nov 8. Review.


Recurrent varicella following steroids and fingolimod in a Multiple Sclerosis patient.

Ferraro D, De Biasi S, Vitetta F, Simone AM, Federzoni L, Borghi V, Cossarizza A, Nichelli PF, Sola P.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1059-61. doi: 10.1007/s11481-013-9510-4. Epub 2013 Oct 27. No abstract available.


Ligand-gated purinergic receptors regulate HIV-1 Tat and morphine related neurotoxicity in primary mouse striatal neuron-glia co-cultures.

Sorrell ME, Hauser KF.

J Neuroimmune Pharmacol. 2014 Mar;9(2):233-44. doi: 10.1007/s11481-013-9507-z. Epub 2013 Oct 25.


Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.

Cross S, Önen N, Gase A, Overton ET, Ances BM.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1114-22. doi: 10.1007/s11481-013-9505-1. Epub 2013 Oct 10.


Abstracts of the Convegno Monotematico SIF - Neuroimmune Pharmacology: Challenging Paradigms Beyond Boundaries, November 15th–16th, 2013, Varese, Italy.

[No authors listed]

J Neuroimmune Pharmacol. 2013 Dec;8 Suppl 1:4-47. doi: 10.1007/s11481-013-9497-x. No abstract available.


A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals.

Marcotte TD, Deutsch R, Michael BD, Franklin D, Cookson DR, Bharti AR, Grant I, Letendre SL; CHARTER Group.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1123-35. doi: 10.1007/s11481-013-9504-2. Epub 2013 Oct 8.


Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives.

Malfitano AM, Laezza C, Saccomanni G, Tuccinardi T, Manera C, Martinelli A, Ciaglia E, Pisanti S, Vitale M, Gazzerro P, Bifulco M.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1077-86. doi: 10.1007/s11481-013-9494-0. Epub 2013 Oct 1.


High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system.

Timmermans S, Bogie JF, Vanmierlo T, Lütjohann D, Stinissen P, Hellings N, Hendriks JJ.

J Neuroimmune Pharmacol. 2014 Mar;9(2):209-17. doi: 10.1007/s11481-013-9502-4. Epub 2013 Sep 26.


Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration.

Woodbury ME, Ikezu T.

J Neuroimmune Pharmacol. 2014 Mar;9(2):92-101. doi: 10.1007/s11481-013-9501-5. Epub 2013 Sep 21. Review.


Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression.

Ferenczy MW, Johnson KR, Steinberg SM, Marshall LJ, Monaco MC, Beschloss AM, Jensen PN, Major EO.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1303-19. doi: 10.1007/s11481-013-9499-8. Epub 2013 Sep 20.


Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response.

Wang J, Zheng S, Xin N, Dou C, Fu L, Zhang X, Chen J, Zhang Y, Geng D, Xiao C, Cui G, Shen X, Lu Y, Wang J, Dong R, Qiao Y, Zhang Y.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1287-302. doi: 10.1007/s11481-013-9498-9. Epub 2013 Sep 17.


Supplemental Content

Loading ...
Support Center